We live in an age where digital healthcare disruption is not a choice, but a necessity. GE Healthcare, a leading medical technology company, has formed strategic alliances with growth-stage MedTech startups through its India Edison Accelerator program (launched in 2019) to co-develop innovative solutions that can meet the challenges of the Indian health sector. The Edison platform uses analytics, machine learning (MI), deep learning, and AI to identify actionable insights, prioritize workflows, and deliver personalized patient care. Startups in the current cohort (cohort 3) focus on areas such as cardiology, oncology, and genomics.
Aira Matrix is one of the startups in this group, providing AI-based solutions for life science applications. Its solutions improve the efficiency, diagnostic accuracy and turnaround times of pathology, microbiology and ophthalmology workflows for pharmaceutical and healthcare laboratories. “We have seen immense benefits from the Edison Accelerator program,” said Chaith Kondragunta, CEO of Aira Matrix. “During the selection process, we realized that the focus of our collaboration will be diagnostic, prognostic and predictive solutions for prostate cancer. We were delighted to share a common goal with GE Healthcare of delivering cost-effective diagnostics, improving patient experience, increasing healthcare workflows and achieving high-throughput processes across the continuum. of care. The startup’s customers and partners include leading hospitals, pharmaceutical companies, CROs and research labs around the world.
Qritive is another start-up to have benefited from the program. With a mission to make cancer diagnosis fast, accurate and affordable, it offers AI-powered solutions that help pathologists in cancer diagnosis. “Solving this healthcare problem can be difficult due to the fragmented nature of the market. GE Healthcare’s India Edison Accelerator program has proven to be the most impactful initiative Qritive has participated in so far,” says its CTO and co-founder, Kaveh Taghipour.
“Startups featured in the third cohort are developing solutions that enable and promote a technology-enabled healthcare ecosystem,” said Girish Raghavan, vice president, Software Engineering, GE Healthcare. For example, a Cohort 3 startup is working on personalizing oncology patient care through genome panel analysis that allows clinicians to match a patient to a therapy that has a higher likelihood of working for him. Cohort 3 startups are also developing solutions aimed at reducing the cognitive load of physicians.
“At GE Healthcare, we want to nurture the startup ecosystem and help create healthcare solutions by leveraging the Edison platform and decades of GE Healthcare expertise,” says Raghavan. Edison enables the deployment of Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant healthcare solutions that can aggregate, correlate, analyze, process, display and share data from connected medical devices, sensors and health information systems. From a business perspective, it will reduce infrastructure and development expenses for startups, as it provides predefined services and opens up global collaboration opportunities.
“Startups can herald the dawn of digital healthcare in India, providing affordable solutions with reach beyond Tier I and II cities,” says Raghavan. The Edison platform currently powers more than 50 applications that span clinical service lines. These solutions are deployed through the cloud, data centers, or on-premises across the healthcare spectrum. “We are also developing a digital health platform to help providers accelerate their digital transformation. This platform aims to enable hospitals and healthcare systems to efficiently deploy clinical, analytics and AI tools that would support improved care delivery,” he said.